Visitors Now:
Total Visits:
Total Stories:
Profile image
By ProactiveInvestors (Reporter)
Contributor profile | More stories
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

NetScientific shares jump as Glycotest secures Japanese patent

Friday, September 23, 2016 9:07
% of readers think this story is Fact. Add your two cents.

(Before It's News)

Netscientific PLC (LON:NSCI) shared gained more than 10% after news that its portfolio company Glycotest has been granted a Japanese patent for its core technology for the early detection of liver disease.

Glycotest – a liver disease diagnostics company – now holds a total of six patents in Australia, the US and Japan.

The patents cover the use of over 50 unique glycoprotein biomarkers which can be used for the diagnosis of liver cancer and other life-threatening liver diseases.

“We are delighted that the Japanese patent can now be added to Glycotest’s rising number of patents which add to the breadth of the IP for its liver disease diagnostic platform,” said NetScientific chief executive François Martelet.

“These granted patents and additional pending applications put Glycotest in a strong position to further protect its proprietary technology as it continues to grow.”

Glycotest added that it expects to put out some more “good news” in the coming year with regards to its intellectual property position.

Shares were up 11% to 84p.

Story by ProactiveInvestors

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.